华仁药业公告，全资子公司腹膜透析液（乳酸盐-G4.25%）取得药品补充申请批准通知书。
华仁药业：腹膜透析液（乳酸盐-G4.25%）取得药品补充申请批准通知书
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.